Source / episode info

• **Episode:**282
• **Title:**Divine Intervention Episode 282 – Combo Podcast (Risk Factors/Prognostic Factors) + Step 2CK Rapid Review (Series 46) + Step 2CK Course Reminder.
• **Published:**2021-01-09
• Source:Episode page

One-liner

This episode provides a combined rapid review of high-yield risk factors and prognostic indicators for critical conditions including ARDS (sepsis), Hodgkin's lymphoma (lymphocyte count/age), BPH (alpha-blocker side effects), coagulopathies (broad spectrum antibiotics/warfarin), and specific cancers like RCC, bladder SCC, and Budd-Chiari Syndrome.

High-yield summary

• ARDS: The biggest risk factor is sepsis. Management involves low tidal volumes, high PEEP, and prone positioning. Low oxygenation is characterized by a very low {PIO}_2/{FIO}_2 ratio (P/F ratio).
• Hodgkin's Lymphoma: Prognostic indicators include young age, finding more lymphocytes on biopsy, and having fewer retropharyngeal cells. It is classically positive for CD-15 and CD-30.
• BPH Management: Alpha-blockers (e.g., Tamsulosin) are used for immediate symptom relief but carry a high risk of orthostatic hypotension due to peripheral vasodilation.
• Coagulopathy Risk Factors: The biggest risk factor for Vitamin K deficiency is the use of broad spectrum antibiotics, which deplete gut flora necessary for {K} synthesis. Warfarin use creates a functional deficiency by inhibiting VKORC.
• Cancer Specificity: Always look for patient-specific risk factors: RCC may be linked to hemangioblastoma (calcifications in the cerebellum); Squamous Cell Carcinoma of the bladder is strongly associated with Schistosoma haematobium infection (Egypt context).
• Budd-Chiari Syndrome (BCS): The biggest risk factor is Polycythemia Vera. Other causes include PNH and OCP use, especially in smokers over 35.

Learning objectives

• Identify the key clinical features and prognostic factors associated with Hodgkin's lymphoma.
• Differentiate between various causes of coagulopathy (e.g., Vitamin K deficiency vs. DIC).
• Recognize the specific risk factors for different types of bladder cancer (TCC vs SCC).
• Understand the pathophysiology and management side effects of alpha-blockers used in BPH.
• Apply critical thinking to determine patient-specific risk factors when diagnosing systemic diseases like RCC or BCS.